PTC THERAPEUTICS, INC.
PTCT
19 insider filings · Latest: May 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 5 4:40 PM | Almstead Zheng Yang | Proposed Sale | 3,989 | $63.38 | $252.8K | — | View → |
| Mar 5, 2026 | Mar 5 4:16 PM | Golden Lee Scott | Proposed Sale | 10,000 | $63.38 | $633.8K | — | View → |
| Feb 19, 2026 | Feb 23 10:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 3,019 | $69.48 | $209.8K | 105,212(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Christine Marie UtterSVP, CHIEF ACCOUNTING OFFICER | Sale | 2,494 | $69.36 | $173.0K | 70,199(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Pierre GravierCHIEF FINANCIAL OFFICER | Sale | 2,992 | $69.36 | $207.5K | 87,318(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Eric PauwelsCHIEF BUSINESS OFFICER | Sale | 3,019 | $69.36 | $209.4K | 77,122(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Matthew B. KleinDirector, CHIEF EXECUTIVE OFFICER | Sale | 7,371 | $69.36 | $511.3K | 387,082(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Lee Scott GoldenEVP & CHIEF MEDICAL OFFICER | Sale | 2,484 | $69.36 | $172.3K | 89,944(D) | View → |
| Feb 18, 2026 | Feb 20 10:20 PM | Neil Gregory AlmsteadCHIEF TECHNICAL OPS OFFICER | Sale | 3,121 | $69.36 | $216.5K | 6,726(I) | View → |
| Feb 18, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 3,081 | $69.36 | $213.7K | 108,231(D) | View → |
| Feb 17, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Sale | 2,813 | $69.29 | $194.9K | 111,312(D) | View → |
| Feb 19, 2026 | Feb 19 2:56 PM | Boulding Mark Elliott | Proposed Sale | 3,019 | $68.57 | $207.0K | — | View → |
| Feb 18, 2026 | Feb 18 10:12 PM | Pauwels Eric | Proposed Sale | 3,019 | $69.36 | $209.4K | — | View → |
| Feb 18, 2026 | Feb 18 10:06 PM | Almstead Zheng Yang | Proposed Sale | 65 | $69.36 | $4.5K | — | View → |
| Feb 18, 2026 | Feb 18 9:56 PM | Almstead Neil Gregory | Proposed Sale | 3,056 | $69.36 | $212.0K | — | View → |
| Feb 18, 2026 | Feb 18 9:56 PM | Gravier Pierre | Proposed Sale | 2,992 | $69.36 | $207.5K | — | View → |
| Feb 18, 2026 | Feb 18 9:55 PM | Utter Christine Marie | Proposed Sale | 2,494 | $69.36 | $173.0K | — | View → |
| Feb 18, 2026 | Feb 18 9:38 PM | Boulding Mark Elliott | Proposed Sale | 3,081 | $69.36 | $213.7K | — | View → |
| Feb 18, 2026 | Feb 18 9:25 PM | Golden Lee Scott | Proposed Sale | 2,484 | $69.36 | $172.3K | — | View → |
| Feb 18, 2026 | Feb 18 9:21 PM | Klein Matthew B. | Proposed Sale | 7,371 | $69.36 | $511.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | May 12 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 3,540 | $46.54 | 41,460(D) | View → |
| Apr 6, 2026 | Apr 8 9:20 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,265 | $39.42 | 6,798(D) | View → |
| Mar 24, 2026 | Mar 26 11:41 PM | Jessica Caroline ChutterDirector | Grant/Award | 6,371 | $64.54 | 2,896(D) | View → |
| Mar 10, 2026 | Mar 12 9:20 PM | Stephanie OkeyDirector | Option Exercise | 15,167 | $33.63 | 0(D) | View → |
| Feb 17, 2026 | Feb 19 10:25 PM | Mark Elliott BouldingEXEC. VP AND CLO | Option Exercise | 2,813 | $25.69 | 22,501(D) | View → |